Reports of sequencing of SARS-CoV-2 from 23 nasopharyngeal swab samples of Covid-19 patients sent from PGIMER in Chandigarh were received on Thursday from NCDC in New Delhi, the hospital said on Sunday. The presence of the double mutant B.1.617 variant having the signature mutations L452R and E484Q has been confirmed in 22 per cent (5/23) of the samples after sequencing, said Jagat Ram, Director PGIMER.
Reports of sequencing of SARS-CoV-2 from 23 nasopharyngeal swab samples of Covid-19 patients sent from PGIMER in Chandigarh were received on Thursday from NCDC in New Delhi, the hospital said on Sunday. The presence of the double mutant B.1.617 variant having the signature mutations L452R and E484Q has been confirmed in 22 per cent (5/23) of the samples after sequencing, said Jagat Ram, Director PGIMER. May 17, 2021 at 07:43AM https://ift.tt/3bw6TEG
No comments:
Post a Comment